RF
60
-3
BAX
48
-2
STT
68
-3
USB
64
-2
PLD
45
5
MCK
71
-3
AIZ
49
-3
HBI
62
-5
ABBV
55
-2
AKAM
37
-2
DUK
49
-3
JNJ
57
-2
TGNA
48
-5
NTRS
64
-6
PRU
44
-7
BWA
52
-3
XOM
40
-4
MA
67
2
PNW
60
-3
CPB
40
-4
RF
60
-3
BAX
48
-2
STT
68
-3
USB
64
-2
PLD
45
5
MCK
71
-3
AIZ
49
-3
HBI
62
-5
ABBV
55
-2
AKAM
37
-2
DUK
49
-3
JNJ
57
-2
TGNA
48
-5
NTRS
64
-6
PRU
44
-7
BWA
52
-3
XOM
40
-4
MA
67
2
PNW
60
-3
CPB
40
-4
Financhill
Back

NewLake Capital Partners Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
46

NLCP
NewLake Capital Partners

Last Price:
$14.25
Seasonality Move:
-5.72%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.40
Seasonality Move:
0.23%
Sell
46
NewLake Capital Partners (NLCP) is a Sell

Is NewLake Capital Partners a Buy, Sell or Hold?

  • The current NewLake Capital Partners [NLCP] share price is $14.39. The Score for NLCP is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NLCP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.41. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NLCP Stock Price Chart

What is NewLake Capital Partners's stock price today?

  • The NewLake Capital Partners share price today is $14.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLCP is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.

NLCP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 48.1 Sell
Chaikin Money Flow: 17934 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 44.4 Sell
Chaikin Money Flow: 1588413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.89 - 18.97) Sell
Bollinger Bands (100): (18.81 - 29.13) Sell

NLCP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.55 Sell
20-day SMA: 14.49 Sell
50-day SMA: 14.37 Buy
200-day SMA: 17.38 Sell
8-day EMA: 14.43 Sell
20-day EMA: 14.47 Sell
50-day EMA: 14.67 Sell
200-day EMA: 16.39 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.49 Sell
20-day SMA: 17.89 Sell
50-day SMA: 19.51 Sell
200-day SMA: 28.26 Sell
8-day EMA: 17.33 Buy
20-day EMA: 17.78 Sell
50-day EMA: 19.75 Sell
200-day EMA: 28.32 Sell

NewLake Capital Partners Earnings Growth & NLCP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.13 per share, and an increase next year of $0.07 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

NewLake Capital Partners Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):